Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$19.73 -0.58 (-2.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Cash & Current Investments (2010 - 2026)

Updated

Acadia Pharmaceuticals' Cash & Current Investments came in at $956.47 million for Q2 2026, up 25.5% from $762 million a year earlier and up 12.3% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Acadia Pharmaceuticals' Cash & Current Investments was $819.69 million, up 8.4% from FY2024.

  • Cash & Current Investments has increased in each of the last three years, with a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $755.99 million in FY2024 (+72.3%), $438.87 million in FY2023 (+5.3%), $416.82 million in FY2022 (-20.0%) and $520.71 million in FY2021 (-17.6%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q2 2010.
  • Year-over-year, Cash & Current Investments has increased for 11 consecutive quarters, with growth averaging 42.7% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2024 (growth of 72.3%), and the weakest in Q1 2022 (a decline of 22.8%).
  • Business Quant data shows ACAD's Cash & Current Investments at $851.46 million (Q1 2026), $819.69 million (Q4 2025) and $847.02 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Acadia Pharmaceuticals 3.39 Bn -84.62 Mn 279.64 Mn 956.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 956.47 Mn
Mar 31, 2026 851.46 Mn
Dec 31, 2025 819.69 Mn
Sep 30, 2025 847.02 Mn
Jun 30, 2025 762.00 Mn
Mar 31, 2025 681.58 Mn
Dec 31, 2024 755.99 Mn
Sep 30, 2024 565.33 Mn
Jun 30, 2024 500.94 Mn
Mar 31, 2024 470.52 Mn
Dec 31, 2023 438.87 Mn
Sep 30, 2023 345.92 Mn
Jun 30, 2023 375.38 Mn
Mar 31, 2023 402.87 Mn
Dec 31, 2022 416.82 Mn
Sep 30, 2022 436.58 Mn
Jun 30, 2022 436.35 Mn
Mar 31, 2022 445.98 Mn
Dec 31, 2021 520.71 Mn
Sep 30, 2021 540.29 Mn
API Access

Acadia Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ACAD&period=max&api_key=YOUR_API_KEY